Emergent BioSolutions to Participate in Investor Conferences

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) announced participation in key investor conferences for Q1 2021. These include:

• 39th Annual J.P. Morgan Healthcare Conference from January 11-14, 2021, with a presentation on January 11 at 8:20 am EST.
• J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference on March 1-3, 2021, with details to be updated on their website.
• Cowen 41st Annual Health Care Conference from March 1-4, 2021, also pending updates.

Webcasts will cover recent developments and financial results.

GAITHERSBURG, Md., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following investor conferences in the first quarter of 2021:

• 39th Annual J.P. Morgan Healthcare Conference
  January 11 to 14, 2021
  Company presentation scheduled on January 11 at 8:20am EST
  
  
• J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference
  March 1 to 3, 2021
  Presentation date and time will be updated on the Emergent website as the information becomes available.
  
  
• Cowen 41st Annual Health Care Conference
  March 1 to 4, 2021
  Presentation date and time will be updated on the Emergent website as the information becomes available.
  

For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.

About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com  

Media Contact:
Miko B. Neri
Senior Director, Global Communications & Public Affairs
240-631-3392
nerim@ebsi.com

FAQ

When is the J.P. Morgan Healthcare Conference for Emergent BioSolutions?

The J.P. Morgan Healthcare Conference will take place from January 11 to 14, 2021, with Emergent's presentation scheduled on January 11 at 8:20 am EST.

What will Emergent BioSolutions discuss at the investor conferences?

Emergent BioSolutions will discuss recent business developments, financial results, and guidance during their presentations.

Where can I find updates on Emergent BioSolutions' conference presentations?

Updates on Emergent BioSolutions' conference presentations will be available on their official website.

What is the stock symbol for Emergent BioSolutions?

The stock symbol for Emergent BioSolutions is EBS.

When will the Cowen Health Care Conference occur for Emergent BioSolutions?

The Cowen 41st Annual Health Care Conference will be held from March 1 to 4, 2021.